Stock screenerAll disclosures →
EDGAR →
AXSM
Conviction 56HealthcareScan · Mon, Aug 10, 2026Three outside up
AXSM$221.14+3.95%
ResistanceSupportVol 14Insider sell2
3
Vol MA14 1.1M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price221.14
Change+3.95%
Gap+1.37%
Rel volume10.34×
Avg volume1M
Avg $ vol225.98M
SMA 20227.66
SMA 50236.16
SMA 200187.77
Price vs 50-6.36%
Price vs 200+17.77%
MA stackmixed
50/200 cross—
Supertrenddown · 238.56
RSI (14)45
MACD hist-1.60
MACD cross—
Stoch %K / %D37 / 20
ADX (14)22
+DI / −DI18 / 23
RSI divergence—
MACD divergence—
ATR %+4.26%
ADR %4.11%
52w high255.17
52w low103.96
From 52w high-13.34%
Above 52w low+112.72%
New 52w highNo
SqueezeOff
Bollinger width19.61%
%B0.35
Donchian pos36.83%
Donchian high245.50
Donchian low206.94
AVWAP (52w high)234.04
vs AVWAP high-5.51%
AVWAP (52w low)184.38
vs AVWAP low+19.94%
OBV trendUp
Chaikin MF (20)0.23
Today vs 20d10.34×
Avg vol (14d)1.1M
Avg vol (20d)1M
Avg $ vol (20d)225.98M
Market cap—
RS 3m (vs SPY)-9.09%
RS 6m (vs SPY)+3.53%
RS line new highNo
Trend template6/8
Technical rank61.0
1 week+4.79%
1 month-5.41%
3 months+1.73%
6 months+21.14%
1 year+111.98%
YTD+23.76%
P/E-59.75
P/B200.49
P/S17.14
P/FCF-116.57
EPS-3.68
Div yield—
ROE-335.56%
ROA-25.67%
Debt/Eq3.44
Current1.39
EV/EBITDA—
Gross margin—
Net margin-28.69%
Rev growth65.55%
EPS growth36.22%
Price target300.38
Target upside41.24%
Analyst ratingBuy
Institutional80.12%
Ent. value10.83B
Revenue191.2M
Net income-64.54M
Gross profit—
Free cash flow-93.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out51.46M
Employees925
ListedThu, Nov 19, 2015
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction56 / 100
Pattern quality—
Tech rank61.0 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside up
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AXSM
No recent disclosed trades by Congress in AXSM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AXSM · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
TABUTEAU HERRIOT Chief Executive Officer · Common Stock · 2026-08-06 | Exercise | 4.66K | $23K | 2026-08-06 | 2026-08-07 |
TABUTEAU HERRIOT Chief Executive Officer · Common Stock · 2026-08-06 | Sell | 4.66K | $997K | 2026-08-06 | 2026-08-07 |
TABUTEAU HERRIOT Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-06 | Exercise | 4.66K | — | 2026-08-06 | 2026-08-07 |
TABUTEAU HERRIOT Chief Executive Officer · Common Stock · 2026-08-05 | Exercise | 45K | $223K | 2026-08-05 | 2026-08-07 |
TABUTEAU HERRIOT Chief Executive Officer · Common Stock · 2026-08-05 | Sell | 45K | $9.5M | 2026-08-05 | 2026-08-07 |
TABUTEAU HERRIOT Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-05 | Exercise | 45K | — | 2026-08-05 | 2026-08-07 |
Mahony Susan Director · Common Stock · 2026-06-10 | Sell | 300 | $74K | 2026-06-10 | 2026-06-10 |
Coleman Mark Director · Common Stock · 2026-06-10 | Sell | 643 | $160K | 2026-06-10 | 2026-06-10 |
Mahony Susan Director · Common Stock · 2026-06-09 | Sell | 300 | $71K | 2026-06-09 | 2026-06-10 |
Saad Mark E Director · Common Stock · 2026-06-08 | Exercise | 1.43K | — | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in AXSM · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.